WINNIPEG, Manitoba, March 2, 2021 – Gowan Canada and ISK Biosciences are excited to announce they have entered into the early stages of an agreement to market Tergeo®, a new, unique PPO inhibitor herbicide, in Canada. Tergeo is a new molecule discovered by FarmHannong, a Korean agrochemical company, and jointly developed by Ishihara Sangyo Kaisha, Ltd. (ISK) and FarmHannong globally.
“Tergeo is a new PPO inhibitor, or group 14 mode of action herbicide, that provides high levels of activity on wild oats in addition to key broadleaf and grass weeds in wheat and corn”, states Garth Render, General Manager for Gowan Canada. “Our research has shown this product will be a valuable tool in an effective herbicide resistance management strategy”, he adds.
Both organizations are ecstatic with the potential of Tergeo and note its rapid and effective pre-seed burn down of grass and broadleaf weeds will be an exciting addition to farmer’s programs across Canada. This partnership and product aligns strongly with Gowan Canada’s overall approach to providing effective tools to farmers and their herbicide resistance management strategies.
Pending PMRA review, Gowan and ISK Biosciences are hopeful to have this new, powerful tool available to farmers in Canada by the Spring of 2022.